BioSpace News Archive

Business

Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update

Conference Call to be Held at 4:30 p.m. EST (1:30 p.m. PST).

November 15, 2017
·
9 min read
Business

Asterias Biotherapeutics Reports Third Quarter Financial Results and Recent Developments

As of September 30, 2017, the combined total of cash, cash equivalents, and available-for-sale securities totaled $20.7 million.

November 15, 2017
·
11 min read
Business

aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update

Research and development expenses were $7.1 million and $10.4 million for the three months ended September 30, 2017 and 2016, respectively. T

November 15, 2017
·
8 min read
Pharm Country

Amarin: Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular Risk

This analysis of RWE is separate from and independent of the RWE analysis referenced in Amarin’s press release on November 12, 2017.

November 15, 2017
·
9 min read
Business

Precision Optics Corporation, Inc. Announces Operating Results for the First Quarter of Fiscal Year 2018 Ended September 30, 2017

Revenues of $1,029,000 compared to $850,000 in the first quarter of fiscal 2017.

November 15, 2017
·
8 min read
Business

Acceleron Announces Appointment of Dr. Karen Smith to its Board of Directors and Departure of Terrance McGuire

Dr. Smith currently serves as Executive Vice President, Global Head R&D, and Chief Medical Officer of Jazz Pharmaceuticals.

November 15, 2017
·
3 min read
Business

TapImmune Provides Third Quarter 2017 Corporate and Clinical Update

A public conference call and live audio webcast is scheduled for today at 4:30 p.m. ET.

November 15, 2017
·
18 min read
Business

Medicure Q3 Results and Conference Call Dates

Medicure will hold a conference call and webcast regarding the results on Wednesday, November 22, 2017 at 7:30 AM Central Time.

November 15, 2017
·
1 min read
Business

Biostar Pharma Announces Its Quarterly Results for Three Months Ended June 30, 2017

Biostar Pharma today announced its financial results for second quarter ended June 30, 2017.

November 15, 2017
·
21 min read
Drug Development

Ascentage Pharma Announces U.S. FDA Acceptance of IND Application for Clinical Study of Novel IAP Inhibitor APG-1387 to Treat Advanced Solid Tumors and Blood Cancers

The Company believes that this dual inhibition may improve its effectiveness for more cancers.

November 15, 2017
·
3 min read